Yuki Nishida - Concepedia

Author

Yuki Nishida

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Nishida, Y., Rupesh K Kesharwani, Y Nishida, Y. NISHIDA, Y. Nishida, Yuji Nishida, Yuki NISHIDA, Yuki Nishida

161

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Institute of Biomedical Innovation, Health and Nutrition Keio University Kyushu University Saga University

About

Yuki Nishida is an author at The University of Texas MD Anderson Cancer Center specializing in chemistry, cancer research, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	173
2	Cell Biology	5	5	173
3	Engineering	4	4	97
4	Natural Sciences	3	3	54
5	Chemical Engineering	2	2	56

Yuki Nishida

Publications

895

Citations

H-Index

Page 1

	Year	Citations
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality Jo Ishizawa, Sarah F. Zarabi, R. Eric Davis, Cancer Cell	2019	339
Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2 Yuki Nishida, Hisashi Miyamori, Erik W. Thompson, Cancer Research	2008	77
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia Takenobu Nii, Varun V. Prabhu, Vivian Ruvolo, Leukemia Hematological MalignancyImipridone Onc212MedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2019	77
Correlation between magnetic and spectral properties of alkoxo-bridged copper(II) complexes with N,N-dialkyldiaminealcohols and N,N-dialkylaminoalcohols Yuki Nishida, F. Numata, S. Kida Inorganica Chimica Acta Magnetic PropertiesAlkoxo-bridged CopperChemical EngineeringEngineeringCoordination Complex	1974	42
Total energy expenditure is comparable between patients with and without diabetes mellitus: Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study Katsutaro Morino, Keiko Kondo, Shigeho Tanaka, BMJ Open Diabetes Research & Care	2019	35
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia Eric Haines, Yuki Nishida, Michael I. Carr, Scientific Reports Mixed-phenotype Acute LeukemiaAcute Leukemia CellsCell DeathPharmacotherapyCancer Biology	2021	32
Electronic structures of square planar cobalt(II), nickel(II) and copper(II) complexes with some N4-macrocyclic ligands [1] Yuki Nishida, Kazuki Hayashida, Akira Sumita, Inorganica Chimica Acta Materials ScienceInorganic ChemistryEngineeringCoordination ComplexElectronic Structures	1978	30
ESR spectra of low-spin iron(III) complexes with several quadridentate schiff bases Yuki Nishida, S. Oshio, S. Kida Inorganica Chimica Acta Low-spin IronInorganic CompoundNatural SciencesCoordination ComplexElectron Paramagnetic Resonance	1977	29
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics Bing Z. Carter, Po Yee Mak, Wenjing Tao, Blood Cancer Journal	2023	29
Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor <scp>PTC</scp>‐209 in acute myeloid leukemia: Implications for leukemia therapy Yuki Nishida, Aya Maeda, Dhruv Chachad, Cancer Science Mixed-phenotype Acute LeukemiaImmunologyAntiviral DrugTumor BiologyMyeloid Neoplasia	2015	27

Page 1